Development and Application of a Robust N‐Glycan Profiling Method for Heightened Characterization of Monoclonal Antibodies and Related Glycoproteins-Reference-Cited by-同舟云学术

Development and Application of a Robust N‐Glycan Profiling Method for Heightened Characterization of Monoclonal Antibodies and Related Glycoproteins

Published:2014-07 Issue:7 Volume:103 Page:1967-1978
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Shang Tanya Q.,Saati Andrew,Toler Kelly N.,Mo Jianming,Li Heyi,Matlosz Tonya,Lin Xi,Schenk Jennifer,Ng Chee‐Keng,Duffy Toni,Porter Thomas J.,Rouse Jason C.

Funder

Marta Czupryn

Pfizer BioTherapeutics Pharmaceutical Sciences organization

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies;Harris;Drug Dev Res,2004

2. A review of therapeutic protein expression by mammalian cells;JM;Bioprocess Int,2008

3. Therapeutic antibodies;Cochvolius;Modern Drug Discov,2003

4. Therapeutic antibodies: Market considerations, disease targets and bioprocessing;Elvin;Int J Pharm,2013

5. Engineering of monoclonal antibodies and antibody‐based fusion proteins: Successes and challenges;Teillaud;Expert Opin Biol Ther,2005

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activation;Journal of Biotechnology;2022-12

2. Technical pipeline for screening microbial communities as a function of substrate specificity through fluorescent labelling;Communications Biology;2022-05-11

3. N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterization;Analytica Chimica Acta;2022-05

4. Challenges and limitations in the studies of glycoproteins: A computational chemist's perspective;Proteins: Structure, Function, and Bioinformatics;2021-09-30

5. Need for a risk-based control strategy for managing glycosylation profile for biosimilar products;Expert Opinion on Biological Therapy;2021-09-01